Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study — Daniel Rutrick (2017) | RDL Network
Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study
Eiko I. Fried, Lynn Boschloo, Claudia D. van Borkulo, Robert A. Schoevers, Jan-Willem Romeijn, Marieke Wichers, Peter de Jonge, Randolph M. Nesse, Francis Tuerlinckx, Denny Borsboom
Discussion(0)
No comments yet. Be the first to comment.